Weight regain upon discontinuation is common with all GLP-1 therapies: Clinical data consistently show that weight regain occurs when GLP-1 receptor agonists are discontinued, typically recovering 50-75% of lost weight within 1-2 years
In contrast, injections avoid these barriers entirely
While many worry about its safety during pregnancy, its impact on breastfeeding is also key
A man who begins enclomiphene but continues to gain weight and sleep poorly may find that his response attenuates over time
Metabolic Syndrome: Metabolic syndrome is a cluster of conditions, including obesity, high blood pressure, elevated blood sugar levels, and abnormal cholesterol levels, that increase the risk of heart disease, stroke, and type 2 diabetes
I do a three-layer closure so that the most superficial layer of skin is perfectly aligned and touching, says Dr